Literature DB >> 1377917

Peptide-containing nerves in labial salivary glands in Sjögren's syndrome.

Y T Konttinen1, M Hukkanen, P Kemppinen, M Segerberg, T Sorsa, M Malmström, S Rose, S Itescu, J M Polak.   

Abstract

OBJECTIVE: The presence and spatial distribution of peptide-containing nerves in labial salivary glands from 10 Sjögren's syndrome patients were compared with those in salivary glands from 7 healthy controls.
METHODS: Immunoperoxidase staining was used to demonstrate vasoactive intestinal peptide (VIP)-immunoreactive (IR) fibers, postganglionic sympathetic fibers containing the C-flanking peptide of neuropeptide Y (CPON), and sensory fibers containing calcitonin gene-related peptide (CGRP) and substance P.
RESULTS: Acini, intralobular ducts, small arteries, and postcapillary veins were richly innervated by VIP-IR fibers, whereas CPON-, CGRP-, and substance P-IR fibers were restricted to blood vessels. Peptide-containing nerves were found surrounding, but not in the middle of, the highly inflamed mononuclear cell areas.
CONCLUSION: This topologic distribution suggests involvement of VIP-IR fibers in vascular, motor, and secretory components of the reflex salivary secretion, whereas the distribution and the vasoactive actions of CPON, CGRP, and substance P suggest a role in the regulation of the salivary gland circulation, and thus of transcapillary flow. Excessive release may contribute to a neurogenic inflammation. Local depletion and absence of trophic neuropeptide stimuli may contribute to acinar atrophy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377917     DOI: 10.1002/art.1780350717

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

2.  Impaired activation of celiac ganglion neurons in vivo after damage to their sympathetic nerve terminals.

Authors:  Thomas O Mundinger; Qi Mei; Gerald J Taborsky
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

3.  Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome.

Authors:  L Kovács; T Török; F Bari; Z Kéri; A Kovács; E Makula; G Pokorny
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

4.  Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjögren's syndrome.

Authors:  L J Dawson; E A Field; A R Harmer; P M Smith
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

5.  Neutral endopeptidase (EC 3.4.24.11) in labial salivary glands in healthy controls and in patients with Sjögren's syndrome.

Authors:  Y T Konttinen; J Törnwall; P Kemppinen; H Uusitalo; T Sorsa; M Hukkanen; J M Polak
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 6.  Vth International Symposium on Sjögren's syndrome. Clinical aspects and therapy.

Authors:  R I Fox
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

7.  Neuropeptides of the autonomic nervous system in Sjögren's syndrome.

Authors:  N Santavirta; Y T Konttinen; J Törnwall; M Segerberg; S Santavirta; M Matucci-Cerinic; H Björvell
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

8.  Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors:  B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

9.  Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction.

Authors:  E-K Tensing; D C Nordström; S Solovieva; K-O Schauman; I Sippo-Tujunen; T Helve; S Natah; J Ma; T F Li; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

10.  Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Domenico Ribatti; Massimo D'Amore; Raffella De Lucro; Maria Antonia Frassanito; Loredana Lorusso; Angelo Vacca; Dario Domenico Lofrumento
Journal:  J Mol Med (Berl)       Date:  2014-02-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.